Cohorte nationale de patients emphysémateux déficitaires en alpha-1 antitrypsine

300-500 patients are expected to be included. At the conclusion incorporation of this cohort into AIR (Alpha-antitrypsin International Registry) will increase the statistical power. This study could also provide the base for prospective trials and research projects.